手术是治疗分化型甲状腺癌的重要手段和有效方法，已在我国各级医院广泛开展。但由于对疾病认识的不足和技术条件的限制，分化型甲状腺癌的外科治疗在不同地区、不同医疗机构和不同医生之间存在着很大的差异，其治疗结果也迥然不同。尽管目前对分化型甲状腺癌的外科治疗还存在一些不同的观点和尚需进一步研究和探讨的问题，但在很多方面已逐渐达成共识，治疗方案也逐渐趋于规范化，现就以下几个方面浅谈加强分化型甲状腺癌的规范化治疗，旨在提高分化型甲状腺癌的诊治水平……
Citation：
刘永锋. Advocate The Normalization of Treating Differentiated Thyroid Carcinoma. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2009, 16(5): 341-343. doi:
Copy
Copyright © the editorial department of CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY of West China Medical Publisher. All rights reserved
| 1. |
Vaiman M, Nagibin A, Hagag P, et al. Subtotal and near total versus total thyroidectomy for the management of multinodular goiter [Ｊ]. World J Surg, 2008; 32(7): 1546-1551.
|
| 2. |
Roh JL, Kim JM, Park CI. Central cervical nodal metastasis from papillary thyroid microcarcinoma: pattern and factors predictive of nodal metastasis [Ｊ]. Ann Surg Oncol, 2008; 15(9): 2482-2486.[３]Palestini N, Borasi A, Cestino L, et al. Is central neck dissection a safe procedure in the treatment of papillary thyroid cancer? Our experience [Ｊ]. Langenbecks Arch Surg, 2008; 393(5): 693-698.[４]Alvarado R, Sywak MS, Delbridge L, et al. Central lymph node dissection as a secondary procedure for papillary thyroid cancer: Is there added morbidity? [Ｊ]. Surgery, 2009; 145(5): 514-518.[５]Sugitani I, Kasai N, Fujimoto Y, et al. A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period [Ｊ]. Surgery, 2004; 135(2): 139-148.
|
- 1. Vaiman M, Nagibin A, Hagag P, et al. Subtotal and near total versus total thyroidectomy for the management of multinodular goiter [Ｊ]. World J Surg, 2008; 32(7): 1546-1551.
- 2. Roh JL, Kim JM, Park CI. Central cervical nodal metastasis from papillary thyroid microcarcinoma: pattern and factors predictive of nodal metastasis [Ｊ]. Ann Surg Oncol, 2008; 15(9): 2482-2486.[３]Palestini N, Borasi A, Cestino L, et al. Is central neck dissection a safe procedure in the treatment of papillary thyroid cancer? Our experience [Ｊ]. Langenbecks Arch Surg, 2008; 393(5): 693-698.[４]Alvarado R, Sywak MS, Delbridge L, et al. Central lymph node dissection as a secondary procedure for papillary thyroid cancer: Is there added morbidity? [Ｊ]. Surgery, 2009; 145(5): 514-518.[５]Sugitani I, Kasai N, Fujimoto Y, et al. A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period [Ｊ]. Surgery, 2004; 135(2): 139-148.
